Edgewise Therapeutics, Inc. (EWTX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $30.35M | +9.9% |
| 2024 | $27.60M | +30.2% |
| 2023 | $21.20M | +4.0% |
| 2022 | $20.39M | +87.9% |
| 2021 | $10.85M | +149.9% |
| 2020 | $4.34M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $30.35M | +9.9% |
| 2024 | $27.60M | +30.2% |
| 2023 | $21.20M | +4.0% |
| 2022 | $20.39M | +87.9% |
| 2021 | $10.85M | +149.9% |
| 2020 | $4.34M | — |